FibroGen Inc.

FibroGen Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
84.33 M
Public Float
78.19 M
FibroGen Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.08
Market Cap
$3.82 B
Shares Outstanding
86.15 M
Public Float
75.13 M

Profile

Address
409 Illinois Street
San Francisco California 94158
United States
Employees -
Website http://www.fibrogen.com
Updated 07/08/2019
FibroGen, Inc. engages in the discovery, development, and commercialization of therapeutics to treat unmet medical needs. It focuses on fibrosis and hypoxia-induced factor biology to generate programs targeting therapeutic areas. The company was founded by Thomas B.

Financials

View All
Created with Highcharts 5.0.14FibroGen Inc.Net Income. Fiscal year is January-December. All values USD Thousands.14 94314 94359 50459 50485 77985 77961 68061 680126 203126 20386 42086 420201320142015201620172018025k50k75k100k125k150k
Created with Highcharts 5.0.14FibroGen Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.102 170102 170137 601137 601180 828180 828179 577179 577125 668125 668212 958212 958201320142015201620172018050k100k150k200k250k

Thomas Byron Neff
Chairman & Chief Executive Officer
Gerald Lema
Independent Director